Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN
Status:
Completed
Trial end date:
2017-07-04
Target enrollment:
Participant gender:
Summary
To assess the pharmacodynamics, safety/tolerability and efficacy of topical Omiganan (CLS001)
in patients with usual type vulvar intraepithelial neoplasia (uVIN).